Europe Viral-Vectored Vaccines Market Research Report Forecast 2017-2021

1 Viral-Vectored Vaccines Market Overview

1.1 Product Overview and Scope of Viral-Vectored Vaccines

1.2 Classification of Viral-Vectored Vaccines

1.2.1 Type 1

1.2.2 Type 2

1.2.3 Type 3

1.3 Application of Viral-Vectored Vaccines

1.3.2 Application 1

1.3.3 Application 2

1.3.4 Application 3

1.4 Viral-Vectored Vaccines Market States Status and Prospect (2012-2021) by Countries

1.4.1 Germany

1.4.2 France

1.4.3 UK

1.4.4 Russia

1.4.5 Italy

1.4.6 Spain

1.4.7 Benelux

1.5 Europe Market Size (Value and Volume) of Viral-Vectored Vaccines (2012-2021)

1.5.1 Europe Viral-Vectored Vaccines Sales and Growth Rate (2012-2021)

1.5.2 Europe Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)

2 Europe Economic Impact on Viral-Vectored Vaccines Industry

2.1 Europe Macroeconomic Analysis

2.2 Europe Macroeconomic Environment Development Trend

3 Viral-Vectored Vaccines Manufacturing Cost Analysis

3.1 Viral-Vectored Vaccines Key Raw Materials Analysis

3.1.1 Key Raw Materials

3.1.2 Price Trend of Key Raw Materials

3.1.3 Key Suppliers of Raw Materials

3.1.4 Market Concentration Rate of Raw Materials

3.2 Proportion of Manufacturing Cost Structure

3.2.1 Raw Materials

3.2.2 Labor Cost

3.2.3 Manufacturing Process Analysis of Viral-Vectored Vaccines

4 Industrial Chain, Sourcing Strategy and Downstream Buyers

4.1 Viral-Vectored Vaccines Industrial Chain Analysis

4.2 Upstream Raw Materials Sourcing

4.3 Raw Materials Sources of Viral-Vectored Vaccines Major Manufacturers in 2015

4.4 Downstream Buyers

5 Europe Viral-Vectored Vaccines Market Analysis by Manufacturers, Type and Application

5.1 Europe Viral-Vectored Vaccines Market Competition by Manufacturers

5.1.1 Europe Viral-Vectored Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)

5.1.2 Europe Viral-Vectored Vaccines Revenue and Share by Manufacturers (2015 and 2016)

5.2 Europe Viral-Vectored Vaccines (Volume and Value) by Type

5.2.1 Europe Viral-Vectored Vaccines Sales and Market Share by Type (2012-2017)

5.2.2 Europe Viral-Vectored Vaccines Revenue and Market Share by Type (2012-2017)

5.3 Europe Viral-Vectored Vaccines (Volume and Value) by Countries

5.3.1 Europe Viral-Vectored Vaccines Sales and Market Share by Countries (2012-2017)

5.3.2 Europe Viral-Vectored Vaccines Revenue and Market Share by Countries (2012-2017)

5.4 Europe Viral-Vectored Vaccines (Volume) by Application

6 Germany Viral-Vectored Vaccines (Volume, Value and Sales Price)

6.1 Germany Viral-Vectored Vaccines Sales and Value (2012-2017)

6.1.1 Germany Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)

6.1.2 Germany Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)

6.1.3 Germany Viral-Vectored Vaccines Sales Price Trend (2012-2017)

6.2 Germany Viral-Vectored Vaccines Sales and Market Share by Manufacturers

6.3 Germany Viral-Vectored Vaccines Sales and Market Share by Type

6.4 Germany Viral-Vectored Vaccines Sales and Market Share by Application

7 France Viral-Vectored Vaccines (Volume, Value and Sales Price)

7.1 France Viral-Vectored Vaccines Sales and Value (2012-2017)

7.1.1 France Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)

7.1.2 France Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)

7.1.3 France Viral-Vectored Vaccines Sales Price Trend (2012-2017)

7.2 France Viral-Vectored Vaccines Sales and Market Share by Manufacturers

7.3 France Viral-Vectored Vaccines Sales and Market Share by Type

7.4 France Viral-Vectored Vaccines Sales and Market Share by Application

8 UK Viral-Vectored Vaccines (Volume, Value and Sales Price)

8.1 UK Viral-Vectored Vaccines Sales and Value (2012-2017)

8.1.1 UK Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)

8.1.2 UK Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)

8.1.3 UK Viral-Vectored Vaccines Sales Price Trend (2012-2017)

8.2 UK Viral-Vectored Vaccines Sales and Market Share by Manufacturers

8.3 UK Viral-Vectored Vaccines Sales and Market Share by Type

8.4 UK Viral-Vectored Vaccines Sales and Market Share by Application

9 Russia Viral-Vectored Vaccines (Volume, Value and Sales Price)

9.1 Russia Viral-Vectored Vaccines Sales and Value (2012-2017)

9.1.1 Russia Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)

9.1.2 Russia Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)

9.1.3 Russia Viral-Vectored Vaccines Sales Price Trend (2012-2017)

9.2 Russia Viral-Vectored Vaccines Sales and Market Share by Manufacturers

9.3 Russia Viral-Vectored Vaccines Sales and Market Share by Type

9.4 Russia Viral-Vectored Vaccines Sales and Market Share by Application

10 Italy Viral-Vectored Vaccines (Volume, Value and Sales Price)

10.1 Italy Viral-Vectored Vaccines Sales and Value (2012-2017)

10.1.1 Italy Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)

10.1.2 Italy Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)

10.1.3 Italy Viral-Vectored Vaccines Sales Price Trend (2012-2017)

10.2 Italy Viral-Vectored Vaccines Sales and Market Share by Manufacturers

10.3 Italy Viral-Vectored Vaccines Sales and Market Share by Type

10.4 Italy Viral-Vectored Vaccines Sales and Market Share by Application

11 Spain Viral-Vectored Vaccines (Volume, Value and Sales Price)

11.1 Spain Viral-Vectored Vaccines Sales and Value (2012-2017)

11.1.1 Spain Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)

11.1.2 Spain Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)

11.1.3 Spain Viral-Vectored Vaccines Sales Price Trend (2012-2017)

11.2 Spain Viral-Vectored Vaccines Sales and Market Share by Manufacturers

11.3 Spain Viral-Vectored Vaccines Sales and Market Share by Type

11.4 Spain Viral-Vectored Vaccines Sales and Market Share by Application

12 Benelux Viral-Vectored Vaccines (Volume, Value and Sales Price)

12.1 Benelux Viral-Vectored Vaccines Sales and Value (2012-2017)

12.1.1 Benelux Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)

12.1.2 Benelux Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)

12.1.3 Benelux Viral-Vectored Vaccines Sales Price Trend (2012-2017)

12.2 Benelux Viral-Vectored Vaccines Sales and Market Share by Manufacturers

12.3 Benelux Viral-Vectored Vaccines Sales and Market Share by Type

12.4 Benelux Viral-Vectored Vaccines Sales and Market Share by Application

13 Europe Viral-Vectored Vaccines Manufacturers Analysis

13.1 Bayer HealthCare AG (Germany)

13.1.1 Company Basic Information, Manufacturing Base and Competitors

13.1.2 Product Type, Application and Specification

13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.1.4 Business Overview

13.2 Biogenesis-Bago (Argentina)

13.2.1 Company Basic Information, Manufacturing Base and Competitors

13.2.2 Product Type, Application and Specification

13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.2.4 Business Overview

13.3 Boehringer Ingelheim GmbH (Germany)

13.3.1 Company Basic Information, Manufacturing Base and Competitors

13.3.2 Product Type, Application and Specification

13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.3.4 Business Overview

13.4 Ceva Sante Animale (France)

13.4.1 Company Basic Information, Manufacturing Base and Competitors

13.4.2 Product Type, Application and Specification

13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.4.4 Business Overview

13.5 Heska Corporation (US)

13.5.1 Company Basic Information, Manufacturing Base and Competitors

13.5.2 Product Type, Application and Specification

13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.5.4 Business Overview

13.6 Indian Immunologicals Ltd (India)

13.6.1 Company Basic Information, Manufacturing Base and Competitors

13.6.2 Product Type, Application and Specification

13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.6.4 Business Overview

13.7 Lohmann Animal Health (US)

13.7.1 Company Basic Information, Manufacturing Base and Competitors

13.7.2 Product Type, Application and Specification

13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.7.4 Business Overview

13.8 Merck Animal Health (US)

13.8.1 Company Basic Information, Manufacturing Base and Competitors

13.8.2 Product Type, Application and Specification

13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.8.4 Business Overview

13.9 Merial Ltd. (US)

13.9.1 Company Basic Information, Manufacturing Base and Competitors

13.9.2 Product Type, Application and Specification

13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)

13.9.4 Business Overview

…

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Market Effect Factors Analysis

14.1 Technology Progress/Risk

14.1.1 Substitutes Threat

14.1.2 Technology Progress in Related Industry

14.2 Consumer Needs/Customer Preference Change

14.3 Economic/Political Environmental Change

15 Europe Viral-Vectored Vaccines Market Forecast (2017-2021)

15.1 Germany Market Forecast (2017-2021)

15.2 France Market Forecast (2017-2021)

15.3 UK Market Forecast (2017-2021)

15.4 Russia Market Forecast (2017-2021)

15.5 Italy Market Forecast (2017-2021)

15.6 Spain Market Forecast (2017-2021)

15.7 Benelux Market Forecast (2017-2021)

15.8 Europe Viral-Vectored Vaccines Market Forecast by Type (2017-2021)

15.9 Europe Viral-Vectored Vaccines Market Forecast by Application (2017-2021)

16 Appendix

Table Classification of Viral-Vectored Vaccines

Figure Europe Sales Market Share of Viral-Vectored Vaccines by Type in 2015

Table Application of Viral-Vectored Vaccines

Figure Europe Sales Market Share of Viral-Vectored Vaccines by Application in 2015

Figure Germany Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)

Figure France Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)

Figure UK Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)

Figure Russia Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)

Figure Italy Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)

Figure Spain Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)

Figure Benelux Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)

Figure Europe Viral-Vectored Vaccines Sales and Growth Rate (2012-2021)

Figure Europe Viral-Vectored Vaccines Revenue and Growth Rate (2012-2021)

Table Europe Viral-Vectored Vaccines Sales of Key Manufacturers (2015 and 2016)

Table Europe Viral-Vectored Vaccines Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Viral-Vectored Vaccines Sales Share by Manufacturers

Figure 2016 Viral-Vectored Vaccines Sales Share by Manufacturers

Table Europe Viral-Vectored Vaccines Revenue by Manufacturers (2015 and 2016)

Table Europe Viral-Vectored Vaccines Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Viral-Vectored Vaccines Revenue Share by Manufacturers

Table 2016 Europe Viral-Vectored Vaccines Revenue Share by Manufacturers

Table Europe Viral-Vectored Vaccines Sales and Market Share by Type (2012-2017)

Table Europe Viral-Vectored Vaccines Sales Share by Type (2012-2017)

Figure Sales Market Share of Viral-Vectored Vaccines by Type (2012-2017)

Figure Europe Viral-Vectored Vaccines Sales Growth Rate by Type (2012-2017)

Table Europe Viral-Vectored Vaccines Revenue and Market Share by Type (2012-2017)

Table Europe Viral-Vectored Vaccines Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Viral-Vectored Vaccines by Type (2012-2017)

Figure Europe Viral-Vectored Vaccines Revenue Growth Rate by Type (2012-2017)

Table Europe Viral-Vectored Vaccines Sales and Market Share by Countries (2012-2017)

Table Europe Viral-Vectored Vaccines Sales Share by Countries (2012-2017)

Figure Sales Market Share of Viral-Vectored Vaccines by Countries (2012-2017)

Table Europe Viral-Vectored Vaccines Revenue and Market Share by Countries (2012-2017)

Table Europe Viral-Vectored Vaccines Revenue Share by Countries (2012-2017)

Figure Revenue Market Share of Viral-Vectored Vaccines by Countries (2012-2017)

Table Europe Viral-Vectored Vaccines Sales and Market Share by Application (2012-2017)

Table Europe Viral-Vectored Vaccines Sales Share by Application (2012-2017)

Figure Sales Market Share of Viral-Vectored Vaccines by Application (2012-2017)

Figure Germany Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)

Figure Germany Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)

Figure Germany Viral-Vectored Vaccines Sales Price Trend (2012-2017)

Table Germany Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)

Table Germany Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)

Table Germany Viral-Vectored Vaccines Sales by Type (2015 and 2016)

Table Germany Viral-Vectored Vaccines Market Share by Type (2015 and 2016)

Table Germany Viral-Vectored Vaccines Sales by Application (2015 and 2016)

Table Germany Viral-Vectored Vaccines Market Share by Application (2015 and 2016)

Figure France Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)

Figure France Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)

Figure France Viral-Vectored Vaccines Sales Price Trend (2012-2017)

Table France Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)

Table France Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)

Table France Viral-Vectored Vaccines Sales by Type (2015 and 2016)

Table France Viral-Vectored Vaccines Market Share by Type (2015 and 2016)

Table France Viral-Vectored Vaccines Sales by Application (2015 and 2016)

Table France Viral-Vectored Vaccines Market Share by Application (2015 and 2016)

Figure UK Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)

Figure UK Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)

Figure UK Viral-Vectored Vaccines Sales Price Trend (2012-2017)

Table UK Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)

Table UK Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)

Table UK Viral-Vectored Vaccines Sales by Type (2015 and 2016)

Table UK Viral-Vectored Vaccines Market Share by Type (2015 and 2016)

Table UK Viral-Vectored Vaccines Sales by Application (2015 and 2016)

Table UK Viral-Vectored Vaccines Market Share by Application (2015 and 2016)

Figure Russia Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)

Figure Russia Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)

Figure Russia Viral-Vectored Vaccines Sales Price Trend (2012-2017)

Table Russia Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)

Table Russia Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)

Table Russia Viral-Vectored Vaccines Sales by Type (2015 and 2016)

Table Russia Viral-Vectored Vaccines Market Share by Type (2015 and 2016)

Table Russia Viral-Vectored Vaccines Sales by Application (2015 and 2016)

Table Russia Viral-Vectored Vaccines Market Share by Application (2015 and 2016)

Figure Italy Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)

Figure Italy Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)

Figure Italy Viral-Vectored Vaccines Sales Price Trend (2012-2017)

Table Italy Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)

Table Italy Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)

Table Italy Viral-Vectored Vaccines Sales by Type (2015 and 2016)

Table Italy Viral-Vectored Vaccines Market Share by Type (2015 and 2016)

Table Italy Viral-Vectored Vaccines Sales by Application (2015 and 2016)

Table Italy Viral-Vectored Vaccines Market Share by Application (2015 and 2016)

Figure Spain Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)

Figure Spain Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)

Figure Spain Viral-Vectored Vaccines Sales Price Trend (2012-2017)

Table Spain Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)

Table Spain Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)

Table Spain Viral-Vectored Vaccines Sales by Type (2015 and 2016)

Table Spain Viral-Vectored Vaccines Market Share by Type (2015 and 2016)

Table Spain Viral-Vectored Vaccines Sales by Application (2015 and 2016)

Table Spain Viral-Vectored Vaccines Market Share by Application (2015 and 2016)

Figure Benelux Viral-Vectored Vaccines Sales and Growth Rate (2012-2017)

Figure Benelux Viral-Vectored Vaccines Revenue and Growth Rate (2012-2017)

Figure Benelux Viral-Vectored Vaccines Sales Price Trend (2012-2017)

Table Benelux Viral-Vectored Vaccines Sales by Manufacturers (2015 and 2016)

Table Benelux Viral-Vectored Vaccines Market Share by Manufacturers (2015 and 2016)

Table Benelux Viral-Vectored Vaccines Sales by Type (2015 and 2016)

Table Benelux Viral-Vectored Vaccines Market Share by Type (2015 and 2016)

Table Benelux Viral-Vectored Vaccines Sales by Application (2015 and 2016)

Table Benelux Viral-Vectored Vaccines Market Share by Application (2015 and 2016)

Table Bayer HealthCare AG (Germany) Basic Information List

Table Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Bayer HealthCare AG (Germany) Viral-Vectored Vaccines Sales Market Share (2012-2017)

Table Biogenesis-Bago (Argentina) Basic Information List

Table Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)

Table Biogenesis-Bago (Argentina) Viral-Vectored Vaccines Sales Market Share (2012-2017)

Table Boehringer Ingelheim GmbH (Germany) Basic Information List

Table Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Boehringer Ingelheim GmbH (Germany) Viral-Vectored Vaccines Sales Market Share (2012-2017)

Table Ceva Sante Animale (France) Basic Information List

Table Ceva Sante Animale (France) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)

Table Ceva Sante Animale (France) Viral-Vectored Vaccines Sales Market Share (2012-2017)

Table Heska Corporation (US) Basic Information List

Table Heska Corporation (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Heska Corporation (US) Viral-Vectored Vaccines Sales Market Share (2012-2017)

Table Indian Immunologicals Ltd (India) Basic Information List

Table Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)

Table Indian Immunologicals Ltd (India) Viral-Vectored Vaccines Sales Market Share (2012-2017)

Table Lohmann Animal Health (US) Basic Information List

Table Lohmann Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Lohmann Animal Health (US) Viral-Vectored Vaccines Sales Market Share (2012-2017)

Table Merck Animal Health (US) Basic Information List

Table Merck Animal Health (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)

Table Merck Animal Health (US) Viral-Vectored Vaccines Sales Market Share (2012-2017)

Table Merial Ltd. (US) Basic Information List

Table Merial Ltd. (US) Viral-Vectored Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Merial Ltd. (US) Viral-Vectored Vaccines Sales Market Share (2012-2017).

…

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Viral-Vectored Vaccines

Figure Manufacturing Process Analysis of Viral-Vectored Vaccines

Figure Viral-Vectored Vaccines Industrial Chain Analysis

Table Raw Materials Sources of Viral-Vectored Vaccines Major Manufacturers in 2015

Table Major Buyers of Viral-Vectored Vaccines

Table Distributors/Traders List

Figure Germany Viral-Vectored Vaccines Sales and Growth Rate Forecast (2017-2021)

Figure Germany Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2017-2021)

Figure France Viral-Vectored Vaccines Sales and Growth Rate Forecast (2017-2021)

Figure France Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2017-2021)

Figure UK Viral-Vectored Vaccines Sales and Growth Rate Forecast (2017-2021)

Figure UK Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2017-2021)

Figure Russia Viral-Vectored Vaccines Sales and Growth Rate Forecast (2017-2021)

Figure Russia Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2017-2021)

Figure Italy Viral-Vectored Vaccines Sales and Growth Rate Forecast (2017-2021)

Figure Italy Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2017-2021)

Figure Spain Viral-Vectored Vaccines Sales and Growth Rate Forecast (2017-2021)

Figure Spain Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2017-2021)

Figure Benelux Viral-Vectored Vaccines Sales and Growth Rate Forecast (2017-2021)

Figure Benelux Viral-Vectored Vaccines Revenue and Growth Rate Forecast (2017-2021)

Table Europe Viral-Vectored Vaccines Sales Forecast by Type (2017-2021)

Table Europe Viral-Vectored Vaccines Sales Forecast by Application (2017-2021)